In lymphocytes, the Rel transcription factor is essential in establishing a pattern of gene expression that promotes cell proliferation, survival, and differentiation. Here we show that mitogeninduced expression of interferon (IFN) regulatory factor 4 ( IRF-4 ), a lymphoid-specific member of the IFN family of transcription factors, is Rel dependent. Consistent with IRF-4 functioning as a repressor of IFN-induced gene expression, the absence of IRF-4 expression in c-rel ϪրϪ B cells coincided with a greater sensitivity of these cells to the antiproliferative activity of IFNs. In turn, enforced expression of an IRF-4 transgene restored IFN modulated c-rel ϪրϪ B cell proliferation to that of wild-type cells. This cross-regulation between two different signaling pathways represents a novel mechanism that Rel/nuclear factor B can repress the transcription of IFN-regulated genes in a cell type-specific manner.
Introduction
During antigen and mitogen stimulation of lymphocytes, specific genetic programs are established by the coordinated activation of various signal transduction pathways, which in turn, lead to morphologic changes, cell division, differentiation, and the acquisition of immunological function. The temporal patterns of gene expression that underlie these processes in lymphocytes collectively span a time frame that extends from minutes to days, with the induction of immediate early and early response genes coinciding with that period of mitogenic stimulation required to commit a cell to a program of activation (1) .
One group of transcription factors essential for lymphocyte activation and immune function is the Rel/nuclear factor (NF) 1 -B proteins (2) , homodimers and heterodimers composed of related subunits that are encoded by a small multigene family. Rel/NF-B proteins regulate gene expression by binding to specific decameric sequences ( B elements) located within the transcriptional regulatory regions of cellular genes, particularly those encoding proteins involved in immune, acute phase, and inflammatory responses (3, 4) . The five mammalian Rel/NF-B subunits share a conserved NH 2 -terminal domain (Rel homology domain [RHD] ) that encompass sequences essential for DNA binding, dimerization, and nuclear localization (3) . The 50-and 52-kD forms of NF-B1 and NF-B2, respectively, comprise the RHD and lack intrinsic transcriptional transactivating properties, whereas Rel, RelA, and RelB all possess transactivation domains within their divergent COOH termini (3) . In most cell types, the majority of Rel/NF-B is sequestered as an inactive cytoplasmic complex with inhibitor or I B proteins (5, 6) . Diverse stimuli promote the nuclear translocation of cytoplasmic Rel/NF-B by activating an I B kinase complex (for a review, see reference 2) that phosphorylates conserved serine residues on the I B proteins, targeting them for ubiquitin-dependent proteosome-mediated degradation (5, 6) .
Rel is dispensable for normal embryonic development and hemopoiesis, but is essential for the division, survival, differentiation, and immune function of mature lymphocytes and macrophages (7) (8) (9) (10) (11) . To date, most of the genes known to be direct transcriptional targets of Rel encode cytokines, cytokine receptors, and immune-regulatory molecules such as IL-2, IL-3, GM-CSF, IL-6, TNF-␣ , IL-2R ␣ , and inducible nitric oxide synthase (iNOS [2, 3] ). However, impaired expression of these proteins only partly explains the immune defects exhibited by c-rel ϪրϪ mice. For example, the B cell proliferative defect resulting from the absence of Rel is due to a cell cycle block and enhanced apoptosis (10) . This impaired mitogenic response is a result of the combined failure to induce the expression of prosurvival genes such as A1 (11) , and Rel-regulated genes necessary for G1 progression, the latter of which remain to be identified.
As part of a strategy aimed at identifying genes regulated by Rel, the expression of genes normally induced early in lymphocyte activation were examined in c-rel ϪրϪ B and T cells. Among those surveyed, IFN regulatory factor 4 ( IRF-4 ), a lymphoid-restricted member of the IFN family of transcription factors, emerged as a promising candidate. IRF-4 expression is rapidly induced in resting lymphocytes by mitogens (12) with kinetics that closely follow the nuclear induction of Rel (13) . Like Rel, it also appears to be critical in lymphocyte proliferation, as IRF-4 ϪրϪ B and T cells respond poorly to mitogens (14) and deregulated overexpression of IRF-4 due to the translocation of the gene into the Ig CH locus occurs in a subset of human multiple myelomas (15) . Proteins comprising the IRF family, of which there are at least 10 members, function either as transcriptional activators or repressors (16) . All share a conserved NH 2 -terminal domain required for the recognition and binding of a specific DNA consensus sequence, the IFN stimulation response element (ISRE) found in the promoters of IFN-regulated genes (17, 18) . Although originally identified as mediating the diverse biological activities of type I and type II IFNs (19, 20) , subsequent studies have revealed roles for IRFs that are independent of IFN signaling. These include controlling susceptibility to oncogenic transformation, promoting cell cycle progression, and the induction of growth arrest and programmed cell death (18) . Here we show that IRF-4, a repressor of ISRE-mediated transcription, while normally rapidly upregulated in mitogen stimulated B and T cells is not induced in activated c-rel ϪրϪ lymphocytes. This impaired expression of IRF-4, which coincides with a hyperresponsiveness of c-rel ϪրϪ lymphocytes to type I and type II IFNs and enhanced expression of certain IFN-induced genes, establishes a novel mechanism that Rel/NF-B can regulate IFN-induced gene expression in a cell type-specific fashion.
Materials and Methods
Mice. The generation of the c-rel ϪրϪ (7) and nfkbl1 ϪրϪ (21) mice has been described previously. All mutant mouse strains have been backcrossed for greater than nine generations with C57BL/6 mice.
Genomic Clones, Plasmid Constructs, and Retroviral Expression Vector. Phage genomic clones encompassing the murine IRF-4 gene (12) were a gift of Prof. Tak Mak (Ontario Cancer Institute, Toronto, Canada). Plasmids IRF4 Pst1-chloramphenicol acetyltransferase (CAT), IRF4 H3-CAT, and IRF4 Sph1-CAT consisted of the 2644-bp Pst1-Avr1, 1195-bp Hind3-Avr1, and 498-bp Sph1-Avr1 genomic fragments, respectively, from the murine IRF-4 5 Ј flanking sequence inserted upstream of CAT in the promoterless reporter plasmid pBCAT3 (22) . IRF4 B1 m -CAT and IRF4 B2 m -CAT are derivatives of IRF4 Pst1-CAT, in which NF-B binding sites B1 (5 Ј -GGGGATCCAC-3 Ј at Ϫ 1733 to Ϫ 1724) and B2 (5 Ј -GGGATCCCCC-3 Ј at Ϫ 686 to Ϫ 657) were altered by in vitro mutagenesis (23) to 5 Ј -GGT-CATAAAC-3 Ј and 5 Ј -GTCATCAACC-3 Ј , respectively, or in the case of IRF4 B1 m / B2 m -CAT, where both sites have been mutated. The reporter plasmid pA3luc-ISRE comprising four copies of the ISRE consensus sequence 5 Ј -GTACCAGTTTCG-GTTTCCCTTG-3 Ј inserted upstream of the minimal mouse H2D k promoter in the reporter plasmid pGem-luc (Promega) was provided by H. Thomas (Walter and Eliza Hall Institute for Medical Research). The expression plasmid pCMDIRF-4 was generated by inserting a 2-kb Xba1-Hind3 murine IRF-4 cDNA encompassing the entire IRF-4 coding region into pCMD-8. A cDNA encompassing the murine IRF-4 coding region fused in frame with an NH 2 -terminal FLAG tag was cloned as a BglIIEcoR1 insert into the retroviral expression vector pMSCV-IRES-green fluorescent protein (GFP) (a gift of Dr. L. Van Parijs, California Institute of Technology, Pasadena, CA).
Purification of Primary B and T Lymphocytes. Small resting B and T lymphocytes were purified from the spleens of 6-8-wk-old wild-type, nfkb1 ϪրϪ , and c-rel ϪրϪ mice by negative sorting (10) on a FACS ® or FACStar PLUS™ cell sorter (Becton Dickinson). The purity of all sorted B and T lymphocytes was verified by staining a portion of the cells with PE-labeled anti-B220 or antiThy1 antibodies, respectively (Caltag Labs) and ranged between 95 and 99%.
Cell Culture and Lymphocyte Activation in Tissue Culture. The Jurkat T cell line was maintained in RPMI 1640 supplemented with 8% FCS, and 293T fibroblasts were grown in DMEM/8% FCS. The B cell lines 404.1 and B1.1 have been described previously (11) and were cultured in DMEM/10% FCS/50 M BME. Primary B and T lymphocytes were cultured in the high glucose version of DMEM supplemented with 13 mM folic acid, 250 mM l -asparagine, 50 M 2-ME, and 10% FCS. Spleen cells were cultured at an initial concentration of 10 6 cells/ml, and FACS ® -purified B or T lymphocytes were cultured at an input concentration of 3 ϫ 10 5 cells/ml. All primary B or T cells were stimulated in vitro with LPS (Difco), affinity-purified goat antimouse IgM (Fab Ј ) fragment (Jackson ImmunoResearch Laboratories), rat anti-mouse radioprotective (RP) mAbs (24), Con A (Amersham Pharmacia Biotech), PMA and ionomycin (Sigma Chemical Co.), or plate-coated mouse anti-CD3 and anti-CD28 mAbs as described previously (11) . In proliferation assays for which the effect of IFNs were assessed, either recombinant IFN-␣ or IFN-␥ (gifts of Drs. P. Hertzog, Monash University, Melbourne, Australia, and T. Kay, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia) were added at increasing 10-fold concentrations (1-10 3 U/ml) with the mitogen combinations anti-RP/LPS or Con A/IL-2 (for B and T cells, respectively) for 72 h. Cellular proliferation was measured by adding 0.5 Ci of [ 3 H]thymidine for 6 h. Afterwards, cells were harvested onto glass fiber filters, and incorporated radioactivity was quantitated by scintillation counting.
Transfections, CAT Assays, and Luciferase Assays. Jurkat T cells and 293T fibroblasts were transiently transfected using Superfect (QIAGEN) as described previously (11) . Equimolar amounts (1-2 g) of IRF4-CAT plasmids or the pluc-ISRE reporter plas-mid (1 g) were transfected alone or with a threefold molar excess of pDAMP56, PDAMP56c-rel (25) , pCTax (26) , pCDMI B-␣ m (27) , pCDMIRF-1 (19), pCDMIRF-2 (20), or pCDMIRF-4. After 48 h, Jurkat and 293T cells were harvested and CAT or luciferase assays were performed on cell extracts that had been standardized for protein content. Transfections were performed five times, with a maximum variance of ‫ف‬ 15% observed between replicate experiments.
Retroviral Production and Infection. Retroviral stocks were obtained by Superfect (QIAGEN)-mediated transfection of the pMSCV-IRES-GFP and pMSCV-IRES-GFP:IRF-4 vectors into BOS23 cells as described (28) . B cell lines 404.1 and B1.1 were infected by incubating each of 10 6 cells for 2 h with 0.25 ml ( ‫ف‬ 10 6 virus/ml) of viral stock in 1 ml of media containing 5 g/ ml of polybrene. Cells were washed once, resuspended in 3 ml of complete medium, and incubated for 48 h. Infected cells were identified as GFP ϩ and then cloned in 96-well plates using the cell deposition unit of the FACStar PLUS™ .
Immunoblotting. Total cell extracts from ‫01ف‬ 6 cells boiled in 0.5% SDS were electrophoresed on 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes as described (13) . Filters were incubated with affinity-purified mouse anti-FLAG M2 specific monoclonal Ig (Sigma Chemical Co.) for detection of FLAG-tagged IRF-4. Bound antibody was then revealed by horseradish peroxidase-conjugated goat anti-mouse Ig (Silenus) using enhanced chemiluminescence (Amersham Pharmacia Biotech).
Northern Blot Analysis. Northern blot hybridization on total RNA isolated from cells using RNAgents (Promega) was performed essentially as described (11) . Filters were washed in 0.2ϫ SSC, 0.1% SDS at 65ЊC and exposed to autoradiography at Ϫ70ЊC. For successive hybridizations, filters were boiled in 10 mM EDTA, 0.1% SDS to remove the bound probe before the rehybridization. The probes were 2-kb Xbal-Hind3 murine IRF-4 cDNA (29), and 1.1-kb Pst1 rat glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA (30) inserts radiolabeled with [␣-32 P]dATP by primer extension.
Semiquantitative Reverse Transcription PCR. Total RNA was isolated from mouse primary splenic B cells (10 6 ) and embryonic fibroblasts (3 ϫ 10 5 ) that were nonactivated or stimulated for 8 h with 10 3 IU/ml of recombinant IFN-␣ in the absence or presence of 50 g/ml of LPS using RNAgents (Promega). cDNA synthesis on equivalent amounts of total RNA was performed essentially as described (9) . For semiquantitative PCR, cDNA was added to a cocktail comprising 50 mM KCl, 2 mM MgCl 2 , 10 mM Tris-HCl, pH 8.3, 0.01% (wt/vol) gelatin, 0.5 mM dNTPs, 1 U of Taq polymerase (Ampli Taq: Perkin-Elmer Cetus) and 1 M of each oligonucleotide in a final volume of 50 l. After an initial 5-min denaturation at 94ЊC, the cDNA was amplified for 25 cycles with each cycle programmed for denaturation at 94ЊC for 45 s, annealing at 58ЊC for 60 s, followed by elongation at 72ЊC for 90 s. Samples were then fractionated on a 1% agarose gel. The sequence of the oligonucleotides used for the amplification of murine 2Ј-5Ј oligoadenylate synthetase (OAS) and ␤-actin mRNA were: 2Ј-5ЈOAS, 5Ј oligo CGCTGGACAAGTTCAT-AGAGGATT (nucleotides 70-93, according to the sequence of Ichii et al. [31] ), 3Ј oligo TTTCCTTGATGAACTCTC-CCCGTC (nucleotides 319-342, according to the sequence of Ichii et al. [31] ); and ␤-actin, 5Ј oligo CTGAAGTACCCAT-TGAACATGGC (nucleotides 278-303, according to the sequence of Tokunaga et al. [32] ), 3Ј oligo CAGAGCAGTA-ATCTCCTTCTGCAT (nucleotides 1016-1040 [32] ); the 2Ј-5ЈOAS and ␤-actin PCR products are 272 and 762 nucleotides in length, respectively.
Electrophoretic Mobility Shift Assays. IRF4 B1 and IRF4 B2 probes were prepared by end-labeling the double stranded oligonucleotides 5Ј-TCACTTCTGGGGGATCCACACAACGAG-3Ј and 5Ј-TGAGTACTCAGGGATCCCCCATCTCTT-3Ј, respectively, and electrophoretic mobility shift assays reactions were performed with 1-2 g of nuclear extract as described (13) . For competition analysis, a 50-fold excess of unlabeled IRF4 B1, IRF4 B2, IRF4 B1 m (5Ј-TCACTTCTGGGTCATAAACA-CAACGAG-3Ј), or IRF4 B2 m (5Ј-TGAGTACTCAGTCAT-CAACCATCTCTT-3Ј) competitor DNA was added to the reaction at room temperature 15 min before the addition of radiolabled probe. For supershift analysis, antibodies that specifically recognize NF-B1, RelA, Rel (13), or NF-B2 (sc 298; Santa Cruz Biotechnology) were incubated on ice for 30 min before the addition of radiolabeled probe. All electrophoretic mobility shift assay reactions were incubated for 20 min at room temperature, 2 l of Ficoll dye was added, and the reactions were fractionated on 5% nondenaturing polyacrylamide gels. Gels were then dried and exposed to autoradiography at Ϫ70ЊC.
Results

Rel Induction of Murine IRF-4 Transcription Is Mediated by κB Elements in the Promoter.
In an attempt to identify novel Rel-regulated genes, RNA hybridization studies were performed on c-rel ϪրϪ lymphocytes to examine the expression of genes normally induced during mitogen stimulation with kinetics that parallel Rel translocation into the nucleus. One gene, IRF-4 (also referred to as Pip [29] , IC-SAT [IFN consensus binding protein in activated T cells; 33], or LSIRF [lymphoid IFN stimulatory response factor; 12]), encodes a lymphoid-specific member of the IFN family of transcription factors that is strongly upregulated by various mitogens in normal and nfkb1 ϪրϪ B and T cells within 2 h, but is barely induced in stimulated c-rel ϪրϪ lymphocytes ( Fig. 1) .
To determine if Rel directly regulates IRF-4 transcription, a nested set of murine IRF-4 promoter truncations extending upstream of the 5Ј untranslated region (ϩ177), inserted 5Ј of CAT in a promoterless reporter plasmid (Fig.  2 A; 22) were transiently transfected into Jurkat T cells with or without a c-rel expression vector. Basal activity of the full-length promoter, IRF4 Pst1-CAT (Ϫ2465 to ϩ177) was equivalent to that of the truncated clones, IRF4 H3-CAT (Ϫ1010 to ϩ177) and IRF4 Sph1-CAT (Ϫ320 to ϩ177) (Fig. 2 B, lanes 3, 5, and 7) , indicating that the sequences necessary for basal transcription appear to reside within 320 nucleotides upstream of the transcription start site. In contrast, whereas IRF4 Pst1-CAT was induced 3.5-fold by Rel, the Rel-dependent expression of IRF4 H3-CAT and IRF4 Sph1-CAT was significantly reduced or completely ablated (Fig. 2 B, compare lanes 4, 6, and 8 ). These findings indicated that at least two sequences residing between Ϫ2465 and Ϫ320 were mediating Rel-dependent transcription. As this region of the murine IRF-4 promoter encompassed two putative Rel/NF-B binding sites at Ϫ1733 (B1: 5Ј-GGGGATCCAC-3Ј) and Ϫ686 (B2: 5Ј-GGGATCCCC-3Ј) (12) , the requirement of these elements for Rel-mediated transcription was tested directly by mutating either or both of these sequences. Promoter constructs, IRF4 B1 m -CAT, IRF4 B2 m -CAT, and IRF4 B1 m /B2 m -CAT, that contain either or both mutant B sites within the context of the full-length promoter retained normal basal promoter activity (Fig. 2 B, lanes 3, 9 , 11, and 13). However, mutations in B1 (lane 10) or B2 (lane 12) diminished the Rel-dependent induction of IRF4 Pst1-CAT by twofold, while the disruption of both sites (lane 14) eliminated Rel-induced transcription. These results demonstrate that these two B elements are both necessary and sufficient for Rel-dependent IRF-4 transcription.
Mitogen-induced Nuclear Rel Complexes Bind to Both κB Elements in the IRF-4 Promoter. The ability of the two IRF-4 B sites to bind nuclear Rel complexes was examined by electrophoretic mobility shift assays (Fig. 3) . Single major complexes expressed in quiescent wild-type and c-rel ϪրϪ T cells (Fig. 3 A, lanes 1 and 3) bound B1 (denoted C2) and B2 (denoted C4) probes. Within 2 h of anti-CD3/anti-CD28 stimulation, novel complexes (C1 and C3 for B1 and B2 probes) were detected in wild-type (Fig. 3 A, The composition of complexes binding IRF-4 B1 and B2 in normal resting and mitogen-stimulated T lymphocytes was examined by supershift analysis using antibodies specific for the different Rel/NF-B subunits (Fig. 3 B) .
Mitogen-induced complexes C1 and C3 were supershifted with antibodies specific for NF-B1 (lane 6) and Rel (lane 7), but not RelA (lane 8), demonstrating that both complexes predominantly comprise NF-B1/Rel heterodimers. Although C2 and C4 have similar mobilities to NF-B1 homodimers, neither complex was supershifted with various NF-B1-specific antibodies or antibodies directed to other Rel/NF-B proteins. The identity of protein(s) in C2 and C4 remains to be determined.
Although mitogen-induced IRF-4 expression coincided with the binding of NF-B1/Rel to IRF-4 B1 and B2, the normal induction of IRF-4 mRNA in mitogen-stimulated nfkb1 ϪրϪ lymphocytes prompted us to examine the basis of NF-B1-independent IRF-4 transcription. DNA binding assays performed with nuclear extracts from resting or anti-CD3/anti-CD28 antibody-stimulated nfkb1 ϪրϪ T lymphocytes are shown in Fig. 3 C. IRF-4 B1 and B2 bound complexes in resting cells (lane 1, denoted C6 and C8) and novel complexes of slower mobility (lane 2, denoted C5 and C7) induced in mitogen activated cells. Supershift studies (Fig. 3 D) indicated that the induced complexes C5 and C7 appear to be Rel homodimers, whereas C6 and C8 were not recognized by Rel/NF-B-specific antisera (lanes 2, 3, 4, and 5). While the roles of C6 and C8 in IRF-4 transcription are unknown, ablation of C6 binding by competition with unlabeled IRF-4 B1 mutant probe (Fig. 3 C, lane 4) indicates that this protein(s) does not bind the IRF-4 B1 probe via the consensus B site. Collectively, these data establish that mitogen induced IRF-4 expression coincides with the binding of Rel complexes to both B elements in the IRF-4 promoter.
Rel-deficient B Cells Exhibit Increased Responsiveness to Type I and Type II IFNs. IFN-induced gene expression is controlled by the coordinated interplay of transcriptional activators and repressors (18). IFN-regulated transactivators IRF-1 and ISGF3 induce transcription by binding to
ISREs found in the promoters and enhancers of IFN-regulated genes (18), while a negative regulator such as IRF-2 is thought to repress transcription by competitive binding to these motifs (17) . Since IRF-4 functions as a repressor of IFN-induced gene expression (33, 34) , one consequence of the inability to upregulate IRF-4 expression during the mitogenic activation of c-rel ϪրϪ lymphocytes may be increased responsiveness of these cells to the action of IFNs. Inhibition of normal lymphocyte proliferation by high concentrations of type I and type II IFNs (35, 36) prompted us to compare the proliferative response of normal and c-rel ϪրϪ B cells over a wide range of IFN-␣ and IFN-␥ concentrations (Fig. 4) . The stimulus anti-RP plus LPS was chosen for these experiments because in contrast to individual mitogens which fail to induce c-rel ϪրϪ B cell proliferation (7), certain mitogen or mitogen plus cytokine combinations function synergistically to promote the proliferation of Rel-deficient cells (7, 10) . Inhibition of B cell proliferation over a wide range of IFN-␣ and IFN-␥ concentrations (Figs. 4, A and B) was significantly greater in c-rel ϪրϪ cultures. This heightened sensitivity of c-rel ϪրϪ B cells to the antiproliferative activity of both cytokines was concentration-dependent. While inhibition of c-rel ϪրϪ B cell proliferation was more pronounced with increasing concentrations of IFN-␥ (Fig. 4 C) , the difference in the inhibition of normal and c-rel ϪրϪ B cells by IFN-␣ was maximal at 10 2 IU/ ml (Fig. 4 B) . Consistent with the specificity of IRF-4 induction by Rel in lymphocytes and its proposed role in modulating IFN responsiveness, proliferating c-rel ϪրϪ T cells but not c-rel ϪրϪ fibroblasts display a heightened sensitivity to the antiproliferative activity of IFNs (Grumont, R., unpublished results).
Enforced IRF-4 Expression in c-rel ϪրϪ B Cells Restores Normal IFN Responsiveness.
We have previously shown that surface IgM ϩ c-rel ϪրϪ B cell lines, like primary c-rel ϪրϪ B cells undergo apoptosis upon B cell receptor engagment due in part to an absence of Rel-induced A1 expression (11) . To ascertain if these cell lines could also be useful models in determining whether the Rel-dependent induction of IRF-4 in B cells has a direct role in modulating the responsiveness of proliferating B cells to IFNs, we first examined the expression of IRF-4 in control and c-rel ϪրϪ B cell lines. In contrast to the constitutive expression of IRF-4 in the control B cell line W404.1, IRF-4 mRNA was not detected in the c-rel ϪրϪ B cell line B1.1 (Fig. 5 A) . To determine if an absence of IRF-4 expression in B1.1 was associated with an increased sensitivity to the antiproliferative action of IFNs, both W404.1 and B1.1 were treated with a range of IFN-␣ and IFN-␥ concentrations for 72 h and proliferation assessed by tritiated thymidine incorporation (Fig. 5 B) . Consistent with the trends observed for primary B cells, after 72 h, proliferation of the c-rel ϪրϪ B cell line B1.1 was significantly less over a range of IFN-␣ and IFN-␥ concentrations compared with that of W404.1. The role of IRF-4 in reducing the antiproliferative action of IFNs was examined by infecting the W404.1 and B1.1 cell lines with a retrovirus expressing NH 4 -terminally Flagtagged IRF-4. Clones of each cell line expressing comparable levels of exogeneous IRF-4 (Fig. 5 C) were then treated with IFN-␣ or IFN-␥ for 72 h and proliferation assessed (Fig. 5 D) . These experiments, which showed that enforced expression of IRF-4 restores c-rel ϪրϪ 
Rel Induction of IRF-4 Coincides with a Repression of IFNregulated Gene Expression.
The heightened responsiveness of c-rel ϪրϪ lymphocytes to the action of IFN led us to determine if Rel could be shown to modulate ISRE-dependent transcription. This was determined by comparing ISRE-dependent transcription in Jurkat T cells or 293T embryonic kidney epithelial cells transiently transfected with an ISRE-regulated reporter plasmid and various combinations of expression vectors encoding IRF-1, IRF-2, IRF-4, and Rel (Fig. 6 A) . IRF-1-induced ISRE-dependent transcription was reduced significantly in both cell types by cotransfection with an equimolar concentration of IRF-2 or IRF-4 plasmids (compare lanes 2 and 7 with lanes 3, 4, 8, and 9). However, Rel was only able to repress IRF-1-induced gene expression (sixfold, lane 5) in Jurkat T cells. Consistent with Rel repressing IRF-1-dependent transcription in a lymphoid-specific manner, Northern blot analysis of transiently transfected Jurkat and 293T cells (Fig. 6 B) revealed that IRF-4 mRNA levels were only upregulated in Jurkat T cells transfected with c-rel (lane 4). Collectively, these findings are consistent with Rel repressing ISRE-dependent transcription in a lymphoid-restricted manner by upregulating IRF-4.
IFN-regulated endogeneous gene expression was also examined in c-rel ϪրϪ cells. We focused on the gene encoding the 1.7-kb transcript for 2Ј-5ЈOAS because the molecular basis of its IFN-or IRF-1-induced transcription has been well studied (30, (36) (37) (38) (20, 38) , it was noteworthy that IRF-4 is expressed constitutively in HTLV-1-induced T cell leukemias, but not in other T cell tumors of varying etiology (33) . Consistent with this finding, Tax, a potent HTLV-1-encoded transcriptional activator essential for viral mediated oncogenesis upregulates IRF-4 expression in Jurkat cells (33) . As Tax induces the expression of various cellular genes by activating or enhancing the activity of cellular transcription factors including Rel/NF-B proteins (39, 40) , we examined whether Tax-induced IRF-4 transcription was mediated by Rel/NF-B (Fig. 8) 
Discussion
Previous studies have shown that in lymphocytes, Rel is crucial in promoting cellular activation and the acquisition of immunological function (2) . Consistent with the immunological component of Rel function, cytokine genes such as IL-2, IL-3, and GM-CSF are transcriptional targets of Rel (7, 8) . Here we show that expression of IRF-4, a lymphoid-specific IFN regulatory factor is directly induced by Rel in activated lymphocytes and that an absence of Rel coincides with a heightened responsiveness of lymphocytes to type I and type II IFNs. The implications of this finding for lymphocyte proliferation, viral replication, and the cross-regulation of IFN signaling by Rel/NF-B are discussed.
Rel-dependent Transcription. Here we show mitogeninduced IRF-4 transcription is Rel-dependent and is regulated by two B elements located in the IRF-4 promoter that 1, 3, 5, 7, 9, and 11) or c-rel ϪրϪ  (lanes 2, 4, 6, 8, 10 , and 12) mouse embryonic fibroblasts (lanes 1-6) and B cells (lanes 7-12) that were non-activated (lanes 1, 2, 7, and 8) or stimulated with IFN-␣ (lanes 3, 4, 9, and 10) or LPS plus IFN-␣ (lanes 5, 6, 11, and 12) for 8 h was subjected to semiquantitative reverse transcription PCR using 2Ј-5ЈOAS-and ␤-actin-specific primers. PCR products were fractionated on a 1% agarose gel. bind Rel/NF-B complexes. Although the major nuclear complex induced in lymphocytes that binds to both IRF-4 B elements is NF-B1/Rel, normal upregulation of IRF-4 in nfkb1 ϪրϪ lymphocytes that results from Rel homodimers binding to these sites indicates that NF-B1 is a nonessential heterodimeric partner of Rel in controlling the transcription of this gene. A similar finding has been made for mitogeninduced regulation of A1 expression, which is also under the transcriptional control of Rel/NF-B (11). Together, this establishes that under normal physiological conditions, Rel homodimers can function as transcriptional activators.
Rel/NF-B binding sites 5Ј-GGG G / A RRNN A / C C-3Ј comprise a conserved 5Ј half site, GGG A / G R, and a divergent 3Ј half site. Both dimer partners contribute to DNA binding, with different subunits binding to the half sites with varying affinity (41, 42) . Since NF-B1 preferentially interacts with the conserved 5Ј half site (41), NF-B1 homodimers bind with strongest affinity to symmetrical motifs (41) . By contrast, DNA sequences randomly selected in vitro to bind recombinant Rel homodimers with high affinity (5Ј-NGGRN A / T TTCC-3Ј) exhibit considerable sequence variation (43) . The IRF-4 and A1 B sites, all of which bind NF-B1 homodimers, Rel homodimers, and NF-B1/Rel heterodimers, comprise the consensus sequence 5Ј-G / A GGGATCC A / C A / C -3Ј. As each of these sites shares the invariant core motif 5Ј-GGGATCC-3Ј, we suggest that this may represent a signature sequence for functional Rel/NF-B sites that bind Rel homodimers. Interestingly, the A1 and IRF4 B sites do not conform to the artificial high-affinity Rel consensus sequences, but instead are more closely related to NF-B1 homodimer binding sites (43) . While the reason for this difference is unclear, one plausible explanation may be that physiological B sites need to bind Rel homodimers with lower affinity than the artificial sites which were selected in vitro to favor high-affinity protein-DNA interactions. In contrast to other IRF genes, the expression of IRF-4 is not regulated by type I or type II IFNs, but instead is induced by Rel/NF-B in response to mitogenic stimulation. As IRF-4 is required for lymphocyte proliferation (14) and inhibits IFN-induced transcription (33) , it had been proposed that this novel mode of IRF regulation represents a mechanism that permits lymphocyte activation under conditions normally refractory to cellular proliferations (29, 34) . Particularly as the growth inhibitory activity of IFNs (35) would be detrimental to lymphocyte function during an immune response, attenuating the effects of IFN by upregulating IRF-4 could be envisaged as a means of maximizing the antiviral immune response of B and T cells in a microenvironment with high local concentrations of these cytokines. Certainly, such a dual role for IRF-4 in regulating lymphocyte proliferation and IFN gene expression is compatible with the finding that IRF-4 is a cellular gene induced by HTLV-1 Tax. As retroviral replication is dependent on the division of target cells (46) , Tax induction of IRF-4 would contribute in maintaining an activated cellular state, while aiding HTLV-1-infected cells to evade the anti-viral response by repressing IFN-regulated gene expression.
IRF-4, a Transcriptional Target of Rel: Implications for the
Although IFR-4 is a transcriptional target of Rel that regulates lymphocyte responsiveness to IFNs during cellular activation, the finding that mature B and T cells from young IRF-4 ϪրϪ mice, like c-rel ϪրϪ lymphocytes, proliferate poorly when treated with diverse mitogens (14) indicates that IRF-4 is also important in controlling IFN-independent lymphocyte proliferation. Although these observations support a model in which c-rel ϪրϪ B cell proliferative defects are in part due to an inability to upregulate IRF-4, this appears to be at odds with the finding that lymphoproliferative disorders develop in older IRF-4 ϪրϪ mice (14), but not c-rel ϪրϪ animals (7). The apparent paradox that an absence of IRF-4 can both reduce and increase lymphocyte proliferation supports an emerging idea that normal cellular proliferation requires the balanced expression of IRF transcriptional activators and repressors, and that altering this balance perturbs cell growth (18) . Such a model would also account for the observation that dysregulated overexpression of IRF-4, resulting from a translocation of the gene into the Ig CH locus contributes to the development of multiple myeloma in humans (15) . The finding that IRF-4 is a transcriptional target of Rel may also have important implications for v-Rel-mediated transformation. Because v-Rel lacks part of the Rel transactivation domain, the transcriptional activity of the viral oncoprotein differs from that of Rel (47, 48) . Consequently, a v-Rel-induced change in the normal pattern of IRF-4 expression could perturb cell growth and may help to explain the basis of lymphoid-specific transformation by v-Rel.
Although it remains to be determined which IRF-4-regulated genes are involved in the control of lymphocyte proliferation, 2Ј5ЈOAS represents an interesting candidate. 2Ј5ЈOAS functions to convert ATP into 2Ј-5Ј-oligoadenylate, which in turn activates the latent endonuclease RNase L (49) . In addition to the 2Ј5ЈOAS/RNase L pathway be-ing a key mechanism for inhibiting viral replication (50), activation of this enzyme is also likely to be important in degrading cellular RNA and as a consequence modulating normal cellular functions. Since overexpression of 2Ј5ЈOAS can inhibit cellular proliferation (51), the enhanced expression of 2Ј5ЈOAS in mitogen-activated c-rel ϪրϪ lymphocytes treated with IFN-␣ may account in part for the increased sensitivity of these cells to the antiproliferative action of this cytokine. Ultimately, the identification of direct targets of Rel and genes further along the transcriptional cascade will offer important insights into understanding how Rel regulates cellular processes in response to a variety of extracellular signals.
